Genitourinary Cancer News

Comprehensive molecular profiling feasibly identified potentially actionable mutations among children and adolescents with hard-to-treat cancers, according to results of a prospective study published in JAMA Network Open.

The CDC plans to launch a new registry that could help researchers better understand occupational cancer risk among firefighters.

Genetic sequencing of tumors among children with refractory cancer led to about a quarter of those tested being matched with therapies targeting their specific genetic alteration, according to results of a study scheduled for presentation at ASCO Annual Meeting.

PHILADELPHIA — Effectively treating solid epithelial cancers will require targeting a patient’s somatic cancer mutations, leading to highly complex, individualized treatments, according to Steven A. Rosenberg, MD, PhD, chief of surgery at the NCI.

The FDA approved avelumab in combination with axitinib for first-line treatment of patients with advanced renal cell carcinoma.

Delays in radical cystectomy appeared associated with increased mortality among patients with muscle-invasive bladder cancer, regardless of whether they received neoadjuvant chemotherapy, according to study results published in Cancer.

Hyperprogressive disease did not appear to be related to clinically significant adverse events, age, tumor type or type of immunotherapy among patients with solid tumors in early-phase trials, according to results of a retrospective study published in Cancer.

Researchers at Dana-Farber Cancer Institute are testing a new treatment strategy designed to improve outcomes for patients with kidney cancer at high risk for recurrence after surgery, according to a press release.

A single course of chemotherapy or radiotherapy after testicular cancer surgery appeared to have no significant long-term effect on sperm production among men with early-stage disease, according to results of a prospective study published in Annals of Oncology.

NEW YORK — Petros Grivas, MD, PhD, medical oncologist and clinical director of the genitourinary cancers program at University of Washington and Fred Hutchinson Cancer Research Center, presented two talks at HemOnc Today New York.